Owkin-led Machine Learning Study IDs Possible Cancer Treatment Biomarkers Using Federated Model February 14, 2023
Verve Therapeutics Announces VERVE-101 Awarded Innovation Passport by the UK MHRA for the Treatment of Heterozygous Familial Hypercholesterolemia February 14, 2023
Innovent Announces First Participant Dosed in Phase 2 Study of IBI311 (Anti-IGF-1R Monoclonal Antibody) in Patients with Thyroid Associated Ophthalmopathy February 14, 2023
Protenus is Top Performing Solution in Two Segments Based on 2023 Best in KLAS Report February 8, 2023
Insilico Medicine Receives FDA Orphan Drug Designation for Generative AI Discovered and Designed Drug for Idiopathic Pulmonary Fibrosis February 8, 2023